Oh, yes, we can totally trust the company:

Yes, Chromium is bypassing the entire source code auditing process by downloading a pre-built black box onto people’s computers. But that’s not something we care about, really. We’re concerned with building Google Chrome, the product from Google. As part of that, we provide the source code for others to package if they like. Anybody who uses our code for their own purpose takes responsibility for it. When this happens in a Debian installation, it is not Google Chrome’s behavior, this is Debian Chromium’s behavior. It’s Debian’s responsibility entirely.

Yes, we deliberately hid this listening module from the users, but that’s because we consider this behavior to be part of the basic Google Chrome experience. We don’t want to show all modules that we install ourselves.

If you think this is an excusable and responsible statement, raise your hand now.

Nothing evil about that at all. Nope.

I wonder if they’re pulling this stunt on the Fedora packages as well?

I don’t normally have a camera on my desktop, or a mike plugged in. I keep the camera taped on my laptop. Not sure if I can physically disable the mike, though.

[Update a while later]

I apologize for any confusion. The “quote” above is not a literal one. I just put it in quotes to distinguish from the blogger’s own commentary. It is his paraphrase of what Google says. I’ve changed it to italics.

Congressional Logic

SLS behind schedule? Increase the budget. Commercial Crew behind schedule? Cut the budget.

And of course, Commercial Crew is not in fact behind schedule. If NASA is hedging its bets by buying Soyuz into 2018, that’s because, for good reason, it has no confidence that it will get the needed funding. So Congressional actions become self fulfilling.


bloodstream nanobots.

Eric Drexler foresaw this sort of thing three decades ago. It’s just the beginning.

[Update a while later]

Biotech’s potential new cancer cure:

Newly marketed drugs called checkpoint inhibitors are curing a small percentage of skin and lung cancers, once hopeless cases. More than 60,000 people have been treated with these drugs, which are sold by Merck and Bristol-Myers Squibb. The treatments work by removing molecular brakes that normally keep the body’s T cells from seeing cancer as an enemy, and they have helped demonstrate that the immune system is capable of destroying cancer.

Faster, please.

Biting Commentary about Infinity…and Beyond!